
Overview
Dr. Lode J. Swinnen is a cancer specialist in Baltimore caring for patients with lymphoma. Dr. Swinnen received his M.B.Ch.B. degree from the University of Cape Town Medical School. He completed his residency at Presence Saint Joseph Hospital and performed a fellowship in hematology-oncology at Loyola University Stritch School of Medicine. Dr. Swinnen joined the Johns Hopkins faculty in 2002. His research interests include lymphomas and immunodeficiency-associated malignancies. Dr. Swinnen is a member of the Eastern Cooperative Oncology Group and the National Comprehensive Cancer Network.
Dr. Swinnen is highly rated in 33 conditions, according to our data. His clinical expertise encompasses Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Small Lymphocytic Lymphoma (SLL), Hodgkin Lymphoma, and Bone Marrow Transplant.
Dr. Swinnen is board certified in American Board Of Internal Medicine. He is actively involved in clinical research, co-authoring 79 peer reviewed articles and participating in 2 clinical trials. Dr. Swinnen is currently accepting new patients.
Specialties
Licenses
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE PDP
- PPO
- HMO
- POS
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
10803 Falls Road, Pavilion III STE 1500, Lutherville, MD 21093
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
2 Clinical Trials
Johns Hopkins Kimmel Cancer Center At Green Spring Station
Christine L Hann, completed her MD and Ph.D. at Jefferson Medical College/Thomas Jefferson University follwed by an internal medicine residency at the University of Chicago Hospitals. Following a fellowship at Johns Hopkins University in Hematology and Oncology, Dr. Hann joined the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center as a member of the Upper Aerodigestive Cancer Program and sees patients with non-small cell and small cell lung cancer. Dr. Hann's research focus is on developing novel therapeutics for lung cancer, particularly small cell lung cancer (SCLC) and neuroendocrine tumors (NETs) such as carcinoid tumors of the lung. As a faculty member she is involved in both clinical and laboratory research. Specific research projects include: 1) Studying mechanisms of resistant to small molecule inhibitors of the antiapoptotic protein, BCL-2 using patient-derived xenograft models. Her preclinical work has led to an NCI-sponsored Phase 1/2 clinical trial combining a BCL-2 inhibitor with a TORC1/2 inhibitors which is currently underway (NCT03366103). 2) Preclinical evaluation of various therapeutics including epigenetic modulators (LSD1 inhibitors) and nanoliposome chemotherapy in SCLC PDXs; 3) Modeling and characterizing chemoradiotherapy resistance in preclinical models of SCLC. She, along with Dr. Luigi Marchionni in Biostatistics and Dr. Phuoc Tran in the Department of Radiation Oncology, were recently awarded a 5-year NCI-sponsored U01 grant to study mechanisms of chemoradiation resistance in SCLC. Dr. Hann is PI of several trials in SCLC and NSCLC and is leading investigator-initiated clinical trials in SCLC and NETs. Dr. Hann is highly rated in 14 conditions, according to our data. Her clinical expertise encompasses Small Cell Lung Cancer (SCLC), Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and Squamous Cell Lung Carcinoma. Dr. Hann is board certified in American Board Of Internal Medicine. Dr. Hann is currently accepting new patients.
Johns Hopkins Health Care & Surgery Center - Green Spring Station, Lutherville
Dr. Daniel Laheru is a cancer specialist in Baltimore, caring for patients with pancreatic cancer, colorectal cancer and neuroendocrine cancers. Dr. Laheru serves as co-director of the Skip Viragh Center for Pancreas Cancer Clinical Research and Patient Care at Johns Hopkins Medicine. Dr. Laheru received his undergraduate degree in chemistry from The University of Utah. He earned his M.D. at Baylor College of Medicine. He completed his residency at The University of Utah Hospital and Clinics and performed a fellowship in medical oncology at The Johns Hopkins University School of Medicine and The Johns Hopkins Oncology Center. Dr. Laheru joined the Johns Hopkins faculty in 2001. Dr. Laheru's research interests include pancreatic cancer and chemotherapy resistance in pancreatic cancer. With Elizabeth Jaffee, M.D., he developed a vaccine that supercharges the immune system and causes immune cells, which tend to be tolerant of cancer, to seek out and kill pancreatic cancer cells throughout the body. He has given numerous invited talks on pancreatic cancer and other cancers both nationally and internationally. He has authored over 200 papers focused on pancreatic cancer. Dr. Laheru serves as associate editor of Annals of Pancreatic Cancer. He has been recognized by the American Society of Clinical Oncology with the Young Investigator Award, by the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins as an Isaac and Catharine Hecht Scholar and has been elected to the Miller-Coulson Academy of Clinical Excellence. He is a member of the American College of Physicians, the American Society of Clinical Oncology and the American Association for Cancer Research. Dr. Laheru is highly rated in 27 conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Familial Pancreatic Cancer, Neuroendocrine Tumor, Pancreaticoduodenectomy, and Pancreatectomy. Dr. Laheru is board certified in American Board Of Internal Medicine. Dr. Laheru is currently accepting new patients.
Johns Hopkins Health Care & Surgery Center - Green Spring Station, Lutherville
Stéphanie Gaillard is a medical oncologist who specializes in the treatment of gynecologic malignancies. She recently joined the faculty of the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center and is their Director of Gynecologic Cancer Trials. Dr. Gaillard earned her medical degree and doctoral degree in cancer biology from Duke University. Following medical school, she underwent residency training in Internal Medicine and fellowship training in Medical Oncology at the Johns Hopkins School of Medicine. Dr. Gaillard’s research focuses on the development of clinical trials aimed at improving outcomes by incorporating promising new biologic, targeted, and immune therapies into standard treatment regimens. Her translational research program focuses on understanding the immune environment associated with gynecologic cancers and mechanisms of resistance to current therapies. Dr. Gaillard is highly rated in 10 conditions, according to our data. Her clinical expertise encompasses Ovarian Cancer, Endometrial Cancer, Cervical Cancer, Tissue Biopsy, and Salpingo-Oophorectomy. Dr. Gaillard is board certified in American Board Of Internal Medicine. Dr. Gaillard is currently accepting new patients.
Johns Hopkins Kimmel Cancer Center At Green Spring Station
Dr. William H. Sharfman is an associate professor of oncology and dermatology at the Johns Hopkins University School of Medicine. His areas of clinical expertise include cutaneous oncology, dermatology and immunotherapy. He helped create the well-established Melanoma Program at the Johns Hopkins Kimmel Cancer Center in 1994. Dr. Sharfman serves as the director of cutaneous oncology and clinical co-director for oncology at the Johns Hopkins Melanoma Program. He earned his M.D. from the University of Toledo College of Medicine. He completed his residency at Cleveland Clinic and performed a fellowship in hematology and oncology at Cleveland Clinic. Dr. Sharfman's research interests include novel therapies for high risk and advanced melanoma patients. Dr. Sharfman is highly rated in 16 conditions, according to our data. His clinical expertise encompasses Melanoma, Merkel Cell Carcinoma, Eccrine Porocarcinoma, and Pancreatic Cancer. Dr. Sharfman is board certified in American Board Of Internal Medicine. Dr. Sharfman is currently accepting new patients.
Johns Hopkins Health Care & Surgery Center - Green Spring Station, Lutherville
Dr. Christian Pavlovich is Bernard L. Schwartz Distinguished Professor in Urologic Oncology at the Johns Hopkins University School of Medicine and Director of the Prostate Cancer Active Surveillance Program at the Brady Urological Institute. Dr. Pavlovich treats cancer with an emphasis on minimizing morbidity and maximizing quality of life while offering patients the latest treatment options and techniques. His clinical focus is on prostate and kidney cancer, and on clinical trials regarding detection, surveillance, and immunotherapy. With more than 20 years of experience with minimally-invasive surgery for the treatment of urologic cancers, he is expert in robotic surgery and was named one of the top prostate cancer surgeons in the United States by Newsweek in 2024. In addition, he offers patients modern diagnostic biopsy techniques, and for prostate cancer patients active surveillance and ablative options including cryotherapy and TULSA. Dr. Pavlovich grew up in Washington DC, went to Harvard University, and then earned his medical degree at the University of California, San Francisco (UCSF) School of Medicine. He then completed a urology residency at New York Hospital-Cornell Medical Center and a National Cancer Institute SUO fellowship in urologic oncology before joining the Hopkins faculty in 2001. Dr. Pavlovich has published over 150 peer-reviewed articles, is Associate Editor of The Prostate and is on the Editorial Board of the British Journal of Urology International. He was the inaugural Director of the Brady Urological Institute’s SUO Urologic Oncology Fellowship (2014 -2024) and is the recipient of three “best teaching/research mentor” awards from the Urology residents at Johns Hopkins. Dr. Pavlovich speaks English, French, Spanish, German, and Serbo-Croatian. He enjoys spending time with his wife and children, following their pursuits, and skiing, diving, running, wildlife, and the great outdoors. Dr. Pavlovich is highly rated in 7 conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Renal Cell Carcinoma (RCC), Prostatectomy, and Nephrectomy. Dr. Pavlovich is board certified in American Board Of Urology. Dr. Pavlovich is currently accepting new patients.
Sandy Kotiah is a Hematologist Oncology provider practicing medicine in Lutherville, Maryland. Dr. Kotiah is highly rated in 38 conditions, according to our data. Her clinical expertise encompasses Paget Disease of the Breast, Iron Deficiency Anemia, Childhood Iron Deficiency Anemia, Anemia, and Bone Marrow Aspiration. Dr. Kotiah is board certified in American Board Of Internal Medicine - Medical Oncology, 2010 and American Board Of Internal Medicine - Hematology, 2010. Dr. Kotiah is currently accepting new patients.
Frequently Asked Questions about Dr. Lode J. Swinnen
How do I make an appointment with Dr. Lode J. Swinnen?
You can book an appointment with Dr. Lode J. Swinnen by calling their office at 410-583-2970. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Lode J. Swinnen a top-rated expert for Non-Hodgkin Lymphoma?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Lode J. Swinnen is classified as an Distinguished expert for Non-Hodgkin Lymphoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Lode J. Swinnen specialize in?
While Dr. Lode J. Swinnen is a Oncology, they have specific expertise in Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), and Small Lymphocytic Lymphoma (SLL). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.
Does Dr. Lode J. Swinnen participate in research or clinical trials?
Yes. Dr. Lode J. Swinnen has published 79 articles and abstracts on conditions like Non-Hodgkin Lymphoma. You can view a list of Dr. Lode J. Swinnen's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Lode J. Swinnen accept my insurance?
Dr. Lode J. Swinnen accepts most major insurance plans, including Aetna and CareFirst. We recommend calling the office directly at 410-583-2970 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- B-Cell LymphomaDr. Swinnen isDistinguished. Learn about B-Cell Lymphoma.
- Chronic B-Cell Leukemia (CBCL)Dr. Swinnen isDistinguished. Learn about Chronic B-Cell Leukemia (CBCL).
- Chronic Lymphocytic Leukemia (CLL)Dr. Swinnen isDistinguished. Learn about Chronic Lymphocytic Leukemia (CLL).
- Diffuse Large B-Cell Lymphoma (DLBCL)Dr. Swinnen isDistinguished. Learn about Diffuse Large B-Cell Lymphoma (DLBCL).
- Follicular LymphomaDr. Swinnen isDistinguished. Learn about Follicular Lymphoma.
- Hodgkin LymphomaDr. Swinnen isDistinguished. Learn about Hodgkin Lymphoma.
- Large-Cell Immunoblastic LymphomaDr. Swinnen isDistinguished. Learn about Large-Cell Immunoblastic Lymphoma.
- Mantle Cell Lymphoma (MCL)Dr. Swinnen isDistinguished. Learn about Mantle Cell Lymphoma (MCL).
- Non-Hodgkin LymphomaDr. Swinnen isDistinguished. Learn about Non-Hodgkin Lymphoma.
- Small Lymphocytic Lymphoma (SLL)Dr. Swinnen isDistinguished. Learn about Small Lymphocytic Lymphoma (SLL).
- Advanced
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Swinnen isAdvanced. Learn about Acute Myeloid Leukemia (AML).
- AgranulocytosisDr. Swinnen isAdvanced. Learn about Agranulocytosis.
- Bone Marrow TransplantDr. Swinnen isAdvanced. Learn about Bone Marrow Transplant.
- Classical Hodgkin LymphomaDr. Swinnen isAdvanced. Learn about Classical Hodgkin Lymphoma.
- Febrile NeutropeniaDr. Swinnen isAdvanced. Learn about Febrile Neutropenia.
- Gastric LymphomaDr. Swinnen isAdvanced. Learn about Gastric Lymphoma.
- Graft Versus Host Disease (GvHD)Dr. Swinnen isAdvanced. Learn about Graft Versus Host Disease (GvHD).
- Hairy Cell Leukemia (HCL)Dr. Swinnen isAdvanced. Learn about Hairy Cell Leukemia (HCL).
- HistiocytosisDr. Swinnen isAdvanced. Learn about Histiocytosis.
- Marginal Zone Lymphoma (MZL)Dr. Swinnen isAdvanced. Learn about Marginal Zone Lymphoma (MZL).
- Multicentric ReticulohistiocytosisDr. Swinnen isAdvanced. Learn about Multicentric Reticulohistiocytosis.
- Multiple MyelomaDr. Swinnen isAdvanced. Learn about Multiple Myeloma.
- Non-Langerhans-Cell HistiocytosisDr. Swinnen isAdvanced. Learn about Non-Langerhans-Cell Histiocytosis.
- Peripheral T-Cell LymphomaDr. Swinnen isAdvanced. Learn about Peripheral T-Cell Lymphoma.
- Primary Lymphoma of the BrainDr. Swinnen isAdvanced. Learn about Primary Lymphoma of the Brain.
- Prolymphocytic LeukemiaDr. Swinnen isAdvanced. Learn about Prolymphocytic Leukemia.
- ReticuloendotheliosisDr. Swinnen isAdvanced. Learn about Reticuloendotheliosis.
- ReticulohistiocytomaDr. Swinnen isAdvanced. Learn about Reticulohistiocytoma.
- Richter SyndromeDr. Swinnen isAdvanced. Learn about Richter Syndrome.
- Rosai-Dorfman DiseaseDr. Swinnen isAdvanced. Learn about Rosai-Dorfman Disease.
- Sea-Blue HistiocytosisDr. Swinnen isAdvanced. Learn about Sea-Blue Histiocytosis.
- T-Cell LymphomaDr. Swinnen isAdvanced. Learn about T-Cell Lymphoma.
- Experienced
- Acute Lymphoblastic Leukemia (ALL)Dr. Swinnen isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Myeloblastic Leukemia with Maturation
- Adult Immune ThrombocytopeniaDr. Swinnen isExperienced. Learn about Adult Immune Thrombocytopenia.
- Anal CancerDr. Swinnen isExperienced. Learn about Anal Cancer.
- Anaplastic Large Cell LymphomaDr. Swinnen isExperienced. Learn about Anaplastic Large Cell Lymphoma.
- AnemiaDr. Swinnen isExperienced. Learn about Anemia.
- Angioimmunoblastic T-cell LymphomaDr. Swinnen isExperienced. Learn about Angioimmunoblastic T-cell Lymphoma.
- Aplastic AnemiaDr. Swinnen isExperienced. Learn about Aplastic Anemia.
- Autoimmune Hemolytic AnemiaDr. Swinnen isExperienced. Learn about Autoimmune Hemolytic Anemia.
- Castleman DiseaseDr. Swinnen isExperienced. Learn about Castleman Disease.
- Childhood Acute Myeloid LeukemiaDr. Swinnen isExperienced. Learn about Childhood Acute Myeloid Leukemia.
- Chronic Familial NeutropeniaDr. Swinnen isExperienced. Learn about Chronic Familial Neutropenia.
- Cutaneous T-Cell Lymphoma (CTCL)Dr. Swinnen isExperienced. Learn about Cutaneous T-Cell Lymphoma (CTCL).
- Hemangioma Thrombocytopenia SyndromeDr. Swinnen isExperienced. Learn about Hemangioma Thrombocytopenia Syndrome.
- Immune Thrombocytopenic Purpura (ITP)Dr. Swinnen isExperienced. Learn about Immune Thrombocytopenic Purpura (ITP).
- LeukemiaDr. Swinnen isExperienced. Learn about Leukemia.
- Lymphomatoid PapulosisDr. Swinnen isExperienced. Learn about Lymphomatoid Papulosis.
- Mediastinal TumorDr. Swinnen isExperienced. Learn about Mediastinal Tumor.
- Midline Lethal GranulomaDr. Swinnen isExperienced. Learn about Midline Lethal Granuloma.
- Multicentric Castleman Disease (MCD)Dr. Swinnen isExperienced. Learn about Multicentric Castleman Disease (MCD).
- Mycosis FungoidesDr. Swinnen isExperienced. Learn about Mycosis Fungoides.
- Myelodysplastic Syndrome (MDS)Dr. Swinnen isExperienced. Learn about Myelodysplastic Syndrome (MDS).
- MyelofibrosisDr. Swinnen isExperienced. Learn about Myelofibrosis.
- Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
- Pneumocystis Jiroveci PneumoniaDr. Swinnen isExperienced. Learn about Pneumocystis Jiroveci Pneumonia.
- POEMS SyndromeDr. Swinnen isExperienced. Learn about POEMS Syndrome.
- Primary Mediastinal B-Cell Lymphoma (PMBCL)
- Smoldering Multiple MyelomaDr. Swinnen isExperienced. Learn about Smoldering Multiple Myeloma.
- Systemic MastocytosisDr. Swinnen isExperienced. Learn about Systemic Mastocytosis.
- ThrombocytopeniaDr. Swinnen isExperienced. Learn about Thrombocytopenia.
- Unicentric Castleman Disease (UCD)Dr. Swinnen isExperienced. Learn about Unicentric Castleman Disease (UCD).
- Waldenstrom MacroglobulinemiaDr. Swinnen isExperienced. Learn about Waldenstrom Macroglobulinemia.





